- €7.42m
- €3.91m
- €8.04m
- 23
- 52
- 33
- 24
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.77 | ||
Price to Tang. Book | 0.87 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.9 | ||
EV to EBITDA | 8.87 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 0.88% | ||
Return on Equity | 2.08% | ||
Operating Margin | 1.03% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 6.17 | 6.66 | 6.32 | 7.16 | 8.04 | 12.9 | n/a | 9.3% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | +311.05 | n/a | n/a | +282.82 | +245.88 | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
UV Germi SA, formerly Bordas Uv Germi SA, is a France-based company engaged in the development of ultraviolet (UV) disinfection technology. It develops and manufactures a range of UV sterilizers for water treatment. Its sterilizers consist of low pressure mercury vapor lamps, which emit a monochromatic wavelength aimed at destruction of microorganisms. The lamps placed either in cylindrical tubes or canalization, with thin layers of water circulating around them and water components absorbing UV radiation. The applications of the Company's technology include dechloramination of swimming pools, treatment of drinking, rain and waste water, fountains and ponds disinfection, industrial water treatment, aquarium cleaning, and air treatment, purification and disinfection, among others.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- December 28th, 2009
- Public Since
- July 21st, 2017
- No. of Employees
- 39
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
Euronext - Paris
- Shares in Issue
- 3,180,050

- Address
- ZAC de la Nau, ST-VIANCE, 19240
- Web
- https://www.uvgermi.fr/
- Phone
- +33 555881888
- Auditors
- Grant Thornton
Upcoming Events for ALUVI
Half Year 2025 UV Germi SA Earnings Release
Similar to ALUVI
AFYREN SA
Euronext - Paris
Alan Allman Associates SA
Euronext - Paris
Aquila SA
Euronext - Paris
Aurea SA
Euronext - Paris
Societe BIC SA
Euronext - Paris
FAQ
As of Today at 23:55 UTC, shares in UV Germi SA are trading at €2.33. This share price information is delayed by 15 minutes.
Shares in UV Germi SA last closed at €2.33 and the price had moved by -32.96% over the past 365 days. In terms of relative price strength the UV Germi SA share price has underperformed the FTSE Global All Cap Index by -34.64% over the past year.
The overall consensus recommendation for UV Germi SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreUV Germi SA does not currently pay a dividend.
UV Germi SA does not currently pay a dividend.
UV Germi SA does not currently pay a dividend.
To buy shares in UV Germi SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €2.33, shares in UV Germi SA had a market capitalisation of €7.42m.
Here are the trading details for UV Germi SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALUVI
Based on an overall assessment of its quality, value and momentum UV Germi SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in UV Germi SA is €6.80. That is 191.47% above the last closing price of €2.33.
Analysts covering UV Germi SA currently have a consensus Earnings Per Share (EPS) forecast of €0.42 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like UV Germi SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -21.81%.
As of the last closing price of €2.33, shares in UV Germi SA were trading -16.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The UV Germi SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €2.33.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on UV Germi SA's directors